TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence December 26, 2008
TCL Archive The March To Deliver Message Of Funding For Cancer Research, Access To Care September 4, 1998